LeMaitre Vascular (LMAT)CEO sold ~$9.35M
George W Lemaitre, CEO at LeMaitre Vascular, sold ~$9.35M of LeMaitre Vascular shares.
- ~$9.35M
- Approx. value · 100K sh @ $93.51
- 1.73M
- Holds after · shares reported
- Traded
- Aug 6, 2025
- Filed
- Aug 8, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Aug 6, 2025 · this disclosureInsiderCEO sold ~$9.35M of LMAT shares in the open market
What came next
- Aug 8, 2025Insider · 2 peopleInsiders: 2 sales (~$323K)
- Aug 11, 2025Insider · 2 peopleInsiders: 5 sales (~$1.6M)
- Aug 12, 2025InsiderDirector sold ~$91K of LMAT shares in the open market
- Oct 11, 2025Federal contract · $24K obligatedDepartment of Veterans Affairs awarded LEMAITRE VASCULAR INC: $24K obligated to date
- Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for LeMaitre Vascular
For LeMaitre Vascular, OQRO holds 5 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LMAT page.
Other recent filings by George W Lemaitre, Chairman and CEO
- SEC Form 4 at LeMaitre Vascular (LMAT)May 20, 2025
- SEC Form 4 at LeMaitre Vascular (LMAT)May 20, 2025
- SEC Form 4 at LeMaitre Vascular (LMAT)May 20, 2025
- SEC Form 4 at LeMaitre Vascular (LMAT)May 20, 2025
- SEC Form 4 at LeMaitre Vascular (LMAT)May 20, 2025
The full history of George W Lemaitre, Chairman and CEO is on the profile page.
How this filing works
Other disclosures at LeMaitre Vascular
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- USAspending.gov award recordAug 5, 2026
- SEC Form 13F-HRAug 4, 2026
- SEC Form 13F-HRJul 24, 2026
Everything OQRO holds on this company is on its LMAT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data